| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |